Acrocyte Therapeutics
UEI: WAKUBM87P2A4
• CAGE: 0QL75
Overview
Awardee Type
Parent
Name
Acrocyte Therapeutics
Website
Headquarters
Fremont, CA
United States
United States
Most Recent Award
March 19, 2026
Calculating
Federal contract recipient
ACROCYTE THERAPEUTICS INC
(UEI WAKUBM87P2A4, CAGE 0QL75)
is headquartered in Fremont CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in May 2023 and
federally registered in
December 2024.
Federal Award Analysis
Acrocyte Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ACROCYTE THERAPEUTICS INC
Division Name
ACROCYTE THERAPEUTICS INC.
UEI
WAKUBM87P2A4
CAGE Code
0QL75
SBA Certifications
None
Self Certifications
Foreign Owned, For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 23, 2023
Initial Registration
Dec. 25, 2024
Last Registration
May 4, 2026
Registration Activation
May 4, 2026
Registration Expiration
May 3, 2027
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
CA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No